Examining Real-World Evidence for Oritavancin Use in Gram-Positive Infections
The challenges of making formulary and clinical decisions based on regulatory studies are significant and the need for real-world clinical experience is increasingly important.
Pan-resistant, Currently Untreatable Gram-Negative Infections Come Closer to Home
The global emergence of antimicrobial resistance among gram-negative species is a major public health concern.
2 Clarke Drive Cranbury, NJ 08512